{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:25:45Z","timestamp":1761488745833},"reference-count":26,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1486,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1111\/j.1468-1293.2011.00938.x","type":"journal-article","created":{"date-parts":[[2011,8,8]],"date-time":"2011-08-08T04:00:57Z","timestamp":1312776057000},"page":"610-619","source":"Crossref","is-referenced-by-count":13,"title":["Does use of antiretroviral therapy regimens with high central nervous system penetration improve survival in HIV-infected adults?"],"prefix":"10.1111","volume":"12","author":[{"given":"H","family":"McManus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PCK","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Nolan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Bloch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Kiertiburanakul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JY","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Mulhall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Petoumenos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Law","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"BJ","family":"Brew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,8,7]]},"reference":[{"key":"10.1111\/j.1468-1293.2011.00938.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1097\/QAD.0b013e32832dc041","article-title":"Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents","volume":"23","author":"Patel","year":"2009","journal-title":"AIDS"},{"key":"10.1111\/j.1468-1293.2011.00938.x-BIB2|cit2","first-page":"1909","article-title":"HIV, the brain, children, HAART and \u2018neuro-HAART\u2019","volume":"23","author":"Brew","year":"2009","journal-title":"a complex mix"},{"key":"10.1111\/j.1468-1293.2011.00938.x-BIB3|cit3","first-page":"121","article-title":"An observed performance test of medication management ability in HIV","volume":"3","author":"Albert","year":"1999","journal-title":"relation to neuropsychological status and medication adherence outcomes"},{"issue":"(Suppl 1)","key":"10.1111\/j.1468-1293.2011.00938.x-BIB4|cit4","first-page":"S19","article-title":"Medication adherence in HIV-infected adults","volume":"18","author":"Hinkin","year":"2004","journal-title":"effect of patient age, cognitive status, and substance abuse"},{"key":"10.1111\/j.1468-1293.2011.00938.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/QAD.0b013e32832c4152","article-title":"Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance","volume":"23","author":"Marra","year":"2009","journal-title":"AIDS"},{"key":"10.1111\/j.1468-1293.2011.00938.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/ana.21225","article-title":"Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy","volume":"63","author":"Bhaskaran","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1468-1293.2011.00938.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1212\/01.wnl.0000316390.17248.65","article-title":"Neurologic disorders are prevalent in HIV-positive outpatients in the Asia-Pacific region","volume":"71","author":"Wright","year":"2008","journal-title":"Neurology"},{"key":"10.1111\/j.1468-1293.2011.00938.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/13550280701258407","article-title":"Neuropsychological deficits in human immunodeficiency virus type 1 clade C-seropositive adults from South India","volume":"13","author":"Gupta","year":"2007","journal-title":"J Neurovirol"},{"key":"10.1111\/j.1468-1293.2011.00938.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3109\/13550280903493914","article-title":"Neurocognitive impairment and psychiatric comorbidity in well-controlled human immunodeficiency virus-infected Thais from the 2NN Cohort Study","volume":"16","author":"Pumpradit","year":"2010","journal-title":"J Neurovirol"},{"key":"10.1111\/j.1468-1293.2011.00938.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1212\/WNL.43.1_Part_1.176","article-title":"Mortality risks in gay men with human immunodeficiency virus infection and cognitive impairment","volume":"43","author":"Mayeux","year":"1993","journal-title":"Neurology"},{"key":"10.1111\/j.1468-1293.2011.00938.x-BIB11|cit11","first-page":"404","article-title":"Psychomotor slowing in HIV infection","volume":"2","author":"Sacktor","year":"1996","journal-title":"a predictor of dementia, AIDS and death"},{"key":"10.1111\/j.1468-1293.2011.00938.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1176\/jnp.10.2.125","article-title":"Mild cognitive impairment and risk of mortality in HIV-1 infection","volume":"10","author":"Wilkie","year":"1998","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1111\/j.1468-1293.2011.00938.x-BIB13|cit13","first-page":"1677","article-title":"Neurological outcomes in late HIV infection","volume":"13","author":"Price","year":"1999","journal-title":"adverse impact of neurological impairment on survival and protective effect of antiviral therapy. AIDS Clinical Trial Group and Neurological AIDS Research Consortium study team"},{"key":"10.1111\/j.1468-1293.2011.00938.x-BIB14|cit14","first-page":"56","article-title":"Changes in cognition during antiretroviral therapy","volume":"52","author":"Tozzi","year":"2009","journal-title":"comparison of 2 different ranking systems to measure antiretroviral drug efficacy on HIV-associated neurocognitive disorders"},{"key":"10.1111\/j.1468-1293.2011.00938.x-BIB15|cit15","first-page":"1699","article-title":"Antiretroviral therapy in HIV infection","volume":"61","author":"Cysique","year":"2004","journal-title":"are neurologically active drugs important?"},{"key":"10.1111\/j.1468-1293.2011.00938.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archneurol.2007.31","article-title":"Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system","volume":"65","author":"Letendre","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1111\/j.1468-1293.2011.00938.x-BIB17|cit17","unstructured":"Letendre S Ellis R Deutsch R et al"},{"key":"10.1111\/j.1468-1293.2011.00938.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1046\/j.1464-2662.2001.00094.x","article-title":"Rates of combination antiretroviral treatment change in Australia, 1997-2000","volume":"3","author":"The Australian HIV Observational Database","year":"2002","journal-title":"HIV Med"},{"key":"10.1111\/j.1468-1293.2011.00938.x-BIB19|cit19","first-page":"174","article-title":"The TREAT Asia HIV Observational Database","volume":"38","author":"Zhou","year":"2005","journal-title":"baseline and retrospective data"},{"key":"10.1111\/j.1468-1293.2011.00938.x-BIB20|cit20","first-page":"644","article-title":"Survival after neuroAIDS","volume":"76","author":"Lanoy","year":"2011","journal-title":"association with antiretroviral CNS Penetration-Effectiveness score"},{"key":"10.1111\/j.1468-1293.2011.00938.x-BIB21|cit21","unstructured":"Garvey L Winston A Sabin C Group UCS."},{"key":"10.1111\/j.1468-1293.2011.00938.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1097\/QAD.0b013e328331910c","article-title":"AIDS-related and non-AIDS-related mortality in the Asia-Pacific region in the era of combination antiretroviral treatment","volume":"23","author":"Falster","year":"2009","journal-title":"AIDS"},{"key":"10.1111\/j.1468-1293.2011.00938.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1468-1293.2006.00397.x","article-title":"CD4 percentage is an independent predictor of survival in patients starting antiretroviral therapy with absolute CD4 cell counts between 200 and 350 cells\/microL","volume":"7","author":"Moore","year":"2006","journal-title":"HIV Med"},{"key":"10.1111\/j.1468-1293.2011.00938.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1258\/0956462991913033","article-title":"Determinants of survival in HIV-positive patients","volume":"10","author":"Baillargeon","year":"1999","journal-title":"Int J STD AIDS"},{"key":"10.1111\/j.1468-1293.2011.00938.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/QAD.0b013e32834171f8","article-title":"Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort","volume":"25","author":"Smurzynski","year":"2011","journal-title":"AIDS"},{"key":"10.1111\/j.1468-1293.2011.00938.x-BIB26|cit26","first-page":"366","article-title":"Clade-specific differences in neurotoxicity of human immunodeficiency virus-1 B and C Tat of human neurons","volume":"63","author":"Mishra","year":"2008","journal-title":"significance of dicysteine C30C31 motif"}],"container-title":["HIV Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-1293.2011.00938.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1468-1293.2011.00938.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,6]],"date-time":"2021-02-06T19:59:32Z","timestamp":1612641572000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1111\/j.1468-1293.2011.00938.x"}},"subtitle":["Effect of neurocART on survival in APHOD"],"short-title":[],"issued":{"date-parts":[[2011,8,7]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,11]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1468-1293.2011.00938.x","relation":{},"ISSN":["1464-2662"],"issn-type":[{"value":"1464-2662","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8,7]]}}}